🇺🇸
United States · US · US:71777-392_5b9e7961-f843-49d8-94b5-a2ce2c9efa46
VITRAKVI
Orange BookUNIISPLATC L01EX12
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerLoxo Oncology, Inc.
CountryUS (United States)
ATC codeL01EX12
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc117177739201100 mL in 1 BOTTLE (71777-392-01)
Annotations
UNII (FDA Substance ID)
PF9462I9HX
LAROTRECTINIB
RxCUI 2105628
Orange Book
N211710
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "PF9462I9HX",
"rxcui": "2105628",
"inchikey": "NYNZQNWKBKUAII-KBXCAEBGSA-N",
"display_name": "LAROTRECTINIB",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"0c8ca614-58b2-4aa4-83d3-0387a8f782fd": {
"match": "brand_token",
"title": "VITRAKVI (LAROTRECTINIB) CAPSULE VITRAKVI (LAROTRECTINIB) SOLUTION, CONCENTRATE [BAYER HEALTHCARE PHARMACEUTICALS INC.]",
"spl_version": "21",
"published_date": "2026-05-25"
}
},
"productid": "71777-392_5b9e7961-f843-49d8-94b5-a2ce2c9efa46",
"productndc": "71777-392",
"dosage_form": "SOLUTION",
"orange_book": {
"appl_no": "211710",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "EQ 20MG BASE/ML",
"product_no": "001",
"approval_date": "Nov 26, 2018"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "LAROTRECTINIB",
"proprietary_name": "VITRAKVI",
"active_ingred_unit": "mg/mL",
"application_number": "NDA211710",
"marketing_category": "NDA",
"nonproprietary_name": "LAROTRECTINIB",
"start_marketing_date": "20181126",
"active_numerator_strength": "20"
}Related drugs
Other records sharing ATC code L01EX12.
Access this data programmatically
Query VITRAKVI and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.